Skin Manifestations of Chronic Kidney Disease

    September 2015 in “ Actas Dermo-Sifiliográficas
    Juan Carlos Robles-Méndez, Osvaldo Vázquez‐Martínez, Jorge Ocampo‐Candiani
    Image of study
    TLDR People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.
    The document reviews the various skin manifestations that can occur in patients with chronic kidney disease (CKD), particularly in the end stages, and the treatments available for these conditions. It notes that severe renal pruritus is common, affecting 50-90% of patients with end-stage CKD, and is associated with increased mortality. The review also discusses conditions such as calciphylaxis, which is characterized by painful skin nodules or plaques and can lead to ulcers with black eschar. Treatments for CKD-related skin conditions include improving hemodialysis quality, medications like steroids, keratolytics, retinoids, and immunosuppressants, and procedures such as parathyroidectomy and kidney transplant. For calciphylaxis, treatments include surgical parathyroidectomy, cinacalcet, and wound management. Other treatments mentioned for various skin conditions include extracorporeal photopheresis, imatinib mesylate, UV-A 1 phototherapy, bisphosphonates, prednisone, sodium thiosulfate, hyperbaric oxygen therapy, autologous skin grafts, and iloprost infusion. The document also covers other skin-related issues in CKD patients, such as pigmentary changes, infections, and nail and hair disorders, with specific treatments for each. Recognizing and treating these skin manifestations is emphasized as crucial for improving CKD patients' quality of life.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  449 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Topical finasteride now the safest possible path?

      in Finasteride/Dutasteride  72 upvotes 4 months ago
      Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.

      community Group Buy for MR antagonist finerenone

      in Product  11 upvotes 1 year ago
      User discusses group buy for finerenone, a third-gen mineralocorticoid antagonist for hair loss treatment. Finerenone inhibits TGFb, NOX, and ROS, and improves renal and cardiac function; topical dose should be no more than 10mg per day.

      community high bloodpressure and crown thinning in early 20s

      in Is this regrowth?  9 upvotes 5 months ago
      A user with kidney disease and high blood pressure experienced hair thinning, especially around the vertex. They are currently using finasteride and oral minoxidil but are considering whether to resume blood pressure medication despite managing symptoms with diet and exercise.

      community Atherosclerosis as cause of balding and treatment

      in Treatment  61 upvotes 1 year ago
      Hair loss may be caused by calcification of capillaries in the scalp, restricting blood flow to hair follicles. A daily treatment regimen including high doses of Vitamins D and K, Magnesium, and Nattokinase could potentially decalcify these capillaries, improving blood flow and hair growth. However, some users warn against excessive Vitamin D intake and emphasize the need for medical consultation.

    Similar Research

    5 / 1000+ results